CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

erin-header4

CELL AND GENE LIVE

22_04_CGL_TalentCrisisWebinar_300x200_OD

 

The CGT market is expected to be worth $5.5 Billion by 2026. Yet, the sector struggles with recruiting and retaining enough experienced candidates needed to bring life-saving treatments to market. Why is that, and what can you do now to overcome the talent crunch? Check out our latest Cell & Gene Live - now available On-Demand.

Cell & Gene Live On-Demand

CELL AND GENE CONTENT COLLECTIONS

22_04_CG_CART_Ebook_300x200

 

While both allogeneic and autologous therapies use similar technologies common to the growth of cells, the scale is different. In this e-book from Cell & Gene, we've curated insightful editorial that concentrates on the advancements of both allogeneic and autologous therapies and how to manufacture them at scale.

More Content Collections